帕金森病生物标志物:弥合诊断和治疗之间的差距
Vaibhav A Chakkarwar1, Yogesh A Kulkarni1
1Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed to be University, V. L. Mehta Road, Vile Parle (West), Mumbai 400056, Maharashtra, India.
Behavioural brain research
|February 23, 2026
概括
发现帕金森病 (PD) 的可靠生物标志物对于早期诊断和治疗至关重要. 最近的研究强调了脑脊液和神经成像中的有希望的生物标志物,以改善患者护理.
科学领域:
- 神经学 神经学
- 生物化学 生物化学
- 遗传学 是一个遗传学.
背景情况:
- 帕金森病 (PD) 诊断依赖于临床症状,通常出现在大量神经退行后.
- 缺乏可靠的生物标志物阻碍了早期检测和有效治疗的发展.
- 目前的诊断方法不足以及时进行干预.
研究的目的:
- 审查帕金森病生物标志物研究的最新进展.
- 探索用于早期诊断和疾病监测的新生物标志物的潜力.
- 讨论这些生物标志物对个性化治疗策略的影响.
主要方法:
- 关于帕金森病生物标志物的当前文献的综述.
- 生物化学,遗传学,成像和炎症标志物的分析.
- 评估已识别的生物标志物的诊断和预后潜力.
主要成果:
- 潜在的生物标志物包括α-synuclein,microRNAs,tau蛋白和炎症分子.
- 脑脊液分析和先进的神经成像显示出早期检测的前景.
- 生物标志物可以帮助区分PD与其他神经疾病,并跟踪疾病的进展.
结论:
- 新兴的生物标志物为改善帕金森病的早期诊断提供了显著的潜力.
- 结合多种生物标志物可能会提高诊断准确度,并使个性化治疗方法成为可能.
- 对这些生物标志物的进一步研究对于推动帕金森病管理至关重要.
相关概念视频
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K